Proteomic analysis of sera from pancreatic cancer patients showed TPI1 as one of the most abundant proteins in patients with poor survival before and after chemotherapy and could be further investigated as a prognostic marker as its levels gradually increase as the disease progresses [123]. The gene discussed is TPI1; the disease is pancreatic neoplasm.